These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 11694816

  • 21. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
    Magnussen H.
    Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A, Richter A, Oster H, Criée CP.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD.
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [Abstract] [Full Text] [Related]

  • 27. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K, Multicentre Study Group.
    Eur Rev Med Pharmacol Sci; 2003 Jan; 7(2):45-55. PubMed ID: 12911119
    [Abstract] [Full Text] [Related]

  • 28. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG, Millar AB, Sykes AP.
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [Abstract] [Full Text] [Related]

  • 29. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
    Ohbayashi H.
    Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
    [Abstract] [Full Text] [Related]

  • 30. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
    Br J Clin Pract; 1997 Jan; 51(1):11-5. PubMed ID: 9158265
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma.
    Adachi M, Ishihara K, Inoue H, Kudo K, Takahashi K, Morita Y, Masuda K, Sakai T, Kato R, Miyamoto T.
    Respirology; 2007 Jul; 12(4):573-80. PubMed ID: 17587425
    [Abstract] [Full Text] [Related]

  • 32. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
    Demedts M, Cohen R, Hawkinson R.
    Int J Clin Pract; 1999 Jul; 53(5):331-8. PubMed ID: 10695095
    [Abstract] [Full Text] [Related]

  • 33. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
    Ayres JG, Simmons JL, Stampone P.
    Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
    [Abstract] [Full Text] [Related]

  • 34. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J, Zuck P, Dennewald G, Dugue P, Grivaux M, Brun P, Severac JC, Ostinelli J, Cheeseman KH.
    Adv Ther; 1996 Jan; 13(1):38-50. PubMed ID: 10172710
    [Abstract] [Full Text] [Related]

  • 35. Inhaled beclomethasone versus placebo for chronic asthma.
    Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW.
    Cochrane Database Syst Rev; 2005 Jan 25; 2005(1):CD002738. PubMed ID: 15674896
    [Abstract] [Full Text] [Related]

  • 36. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
    Pauwels RA, Yernault JC, Demedts MG, Geusens P.
    Am J Respir Crit Care Med; 1998 Mar 25; 157(3 Pt 1):827-32. PubMed ID: 9517598
    [Abstract] [Full Text] [Related]

  • 37. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.
    Dal Negro R, Micheletto C, Tognella S, Mauroner L, Burti E, Turco P, Pomari C, Cantini L.
    J Investig Allergol Clin Immunol; 1999 Mar 25; 9(4):241-7. PubMed ID: 10513351
    [Abstract] [Full Text] [Related]

  • 38. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
    J Aerosol Med; 2002 Mar 25; 15(4):407-14. PubMed ID: 12581507
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.
    Hampel F, Lisberg E, Guérin JC.
    J Asthma; 2000 Aug 25; 37(5):389-98. PubMed ID: 10983616
    [Abstract] [Full Text] [Related]

  • 40. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways.
    Ohbayashi H.
    Respiration; 2007 Aug 25; 74(2):146-53. PubMed ID: 16804291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.